QLC5513 combined with QL1706 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new combination of drugs (QLC5513 and QL1706) for people with advanced or metastatic solid tumors that cannot be removed by surgery or radiation. The goal is to see if this combination is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to take care of yourself (ECOG score 0 or 1).
- Your organs (like liver, kidneys, and bone marrow) need to work well enough.
- Your life expectancy is at least 3 months.
- You have advanced or metastatic solid tumors that can't be treated with surgery or radiation.
- You have at least one tumor that can be seen on a scan (measurable disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called QLS5308 for people with advanced solid tumors that have not responded to standard treatments. The study's goal is to find a safe dose and see how well it works.
This study is testing a new two-in-one immunotherapy drug (QL1706) for people with advanced cancers like lung, breast, colon, or liver cancer that have gotten worse after at least one prior treatment. It aims to see how well the drug works in real-world settings.
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests a new drug called QLS5133 for people with advanced solid tumors that have not responded to other treatments. The drug is given alone, and the study aims to see if it is safe and effective.
This trial tests a combination of two new treatments (QLP2117 and QL2107) for people with advanced solid tumors that have not responded to standard therapy. The goal is to see if the combination can shrink tumors or slow cancer growth.
This trial tests a new drug, QLS5132, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.